PROVIDER FILE · The cost notebook

Mondae Review: The Monthly Price Is Only Part of the Cost

Mondae advertises compounded semaglutide from $69 a month and compounded tirzepatide from $114, but product-page prices differ. Its billing, consultation and cancellation terms deserve a closer look before payment.

A monthly price is useful only when you know what payment it describes. Mondae’s homepage advertises compounded semaglutide from $69 a month and compounded tirzepatide from $114, while their product pages display $87 and $126 per month. Those differences are not explained in the supplied documentation. For someone budgeting for ongoing treatment, the immediate question is therefore not simply whether Mondae looks inexpensive. It is which price applies, what must be paid at checkout, and what financial obligations remain if treatment is not prescribed or an order needs to stop.

Mondae is a telehealth platform operated by Mondae LLC, connecting eligible patients with clinicians and outside dispensing pharmacies. It advertises availability in all 50 states and operates on a cash-pay basis rather than accepting insurance. This documentary review examines its posted offerings and policies consulted October 19, 2026; that consultation date does not establish when each page was updated. The strongest parts of the cost proposition are visible monthly figures and a stated dose-independent rate. The weakest are unresolved plan-price relationships, incomplete billing documentation and conflicting signals about charges before prescription approval.

At a glance

Compounded semaglutide pricing
The homepage advertises from $69/month; the product page displays $87/month alongside one-, three- and six-month options without clearly matching the figure to an option.
Sources: [6] [11]
Compounded tirzepatide pricing
The homepage advertises from $114/month; the product page displays $126/month alongside one-, three- and six-month options, with the applicable option unresolved.
Sources: [6] [7]
Insurance and payment
Mondae and its providers state that they do not accept commercial insurance or participate in Medicare or Medicaid; services are cash-pay.
Sources: [12]
Consultation-charge uncertainty
The homepage says patients are not charged until physician approval, while the refund policy makes consultation fees nonrefundable even without a prescription.
Sources: [6] [5]
Order cancellation boundary
An order can be canceled only before medication has been dispensed or shipped; cancellation eligibility ends at either event.
Sources: [5]

Start with the price differences, not the lowest number

Mondae publishes two different sets of prices for the same named offerings. The homepage uses “from” pricing for compounded semaglutide and compounded tirzepatide; their individual pages show higher monthly amounts. The same pattern extends beyond GLP-1 offerings: sermorelin injection, NAD+ injection and glutathione injection each appear from $95, billed monthly, on the homepage, versus $99 per month on their product pages. These are documented advertisements, not a verified personalized quote. Nothing supplied explains whether the differences reflect plan selection, another condition or inconsistent page information.

The table preserves both figures rather than choosing one as the definitive cost. The product-page amounts are displayed beside duration choices, but the supplied text does not establish which choice produces each amount. Nor does it identify a guaranteed introductory period or subsequent renewal charge. Before using either figure in a household budget, request a written checkout breakdown. Our guide to understanding the first payment explains why a monthly headline and the amount actually collected should be treated as separate questions.

Mondae’s advertised prices; the supplied documentation does not reconcile the homepage and product-page amounts.
OfferingHomepage advertisementProduct-page display and options
Compounded semaglutideFrom $69/month$87/month; one-, three- and six-month options
Compounded tirzepatideFrom $114/month$126/month; one-, three- and six-month options
Sermorelin injectionFrom $95, billed monthly$99/month; one- and three-month options
NAD+ injectionFrom $95, billed monthly$99/month; one- and three-month options
Glutathione injectionFrom $95, billed monthly$99/month; one- and three-month options
Sources: [6] [11] [7] [13] [9] [8]

Plan length does not establish the first bill

The compounded semaglutide and tirzepatide pages offer one-, three- and six-month plan lengths. The other three product pages list one- and three-month choices. Those labels do not establish whether longer plans require advance collection, permit periodic payments or carry a minimum commitment. They also do not establish the amount of medication supplied in any shipment. The supplied documentation leaves the GLP-1 products’ presentation, concentration, administration route and shipment quantity unresolved. A plan’s duration cannot fill those gaps or substitute for the pharmacy label and prescribing information.

Mondae says the monthly price does not increase when a clinician changes the dose. Its broader promise that patients keep their starting price “for life” is conditional on membership remaining active. At the same time, product pages advertise no membership fees. These statements are not necessarily incompatible—a program can use membership language without charging a separate membership fee—but the contractual mechanics remain unclear. There is no documented basis here to specify renewal timing, a cancellation deadline for future charges or what price applies after a membership interruption. See our explanation of billing intervals and prepaid plans.

Sources: [11] [7] [13] [9] [8] [6]

Included guidance is clearer than the complete fee schedule

Product pages pair the monthly amount with “1:1 Provider guidance” and “No membership fees.” The homepage also describes secure portal messaging during treatment, including questions, dosage concerns and requests for follow-up consultations or clinically appropriate adjustments. Those are meaningful descriptions of access, but they are not a comprehensive fee schedule. The material does not establish whether every consultation, laboratory test, administration supply or shipping charge is included. It also gives no dollar amount for the consultation fees referenced in the refund policy, leaving a potentially important budget item undefined.

Insurance does not resolve that uncertainty within Mondae’s stated model. Its terms say neither Mondae nor its providers accept commercial health insurance, participate in commercial networks or enroll in government programs such as Medicare and Medicaid. Choosing the service means paying outside those arrangements. This documents a cash-pay structure, not an assurance of reimbursement through a separate claim. Ask for an itemized statement distinguishing medication, clinical services, supplies and delivery, including any separate biller. Our guide to what a program price includes offers a framework for reading that statement.

Sources: [11] [6] [12] [5]

Resolve the approval-versus-consultation charge conflict

The homepage answers a direct question about not qualifying for treatment with a reassuring statement: “No, you won’t be charged until a physician approves your treatment.” The refund policy, however, states that telehealth consultation fees are nonrefundable, including cases in which medication is not prescribed. The supplied documents do not explain how these promises operate together. It would be premature to conclude either that every unsuccessful applicant pays nothing or that everyone pays a consultation fee. The missing details are the fee amount, the charging event and any applicable exception.

The clinical process starts with an online questionnaire covering medical history, current medications and treatment goals. Mondae says a U.S.-licensed healthcare provider then reviews the information and conducts a consultation to determine appropriateness; a prescription is not guaranteed. Before submitting payment information, ask whether a card authorization differs from a completed charge, whether consultation costs can arise without medication approval, and which written policy controls. Request the answer in a form you can retain. This is a targeted clarification of Mondae’s own conflicting language, not a reason to assume that its evaluation guarantees treatment.

Sources: [6] [5] [11]

Cancellation depends on dispensing, not just shipping

Mondae’s order-cancellation policy sets an early boundary: medication must not yet have been dispensed or shipped. Either event prevents cancellation, so an order that has not left the pharmacy may already be beyond that boundary. For a successfully canceled order before shipping, the policy says a full refund will be issued within five to seven business days. That statement should be read alongside the nonrefundable consultation provision, rather than assumed to erase it. Stopping one order also does not establish that an ongoing membership or future billing has been terminated.

Other refund requests follow a different process. Mondae says refunds are not guaranteed, requests are reviewed only in limited situations, and applicants must provide an order number, purchase date and explanation; supporting documents may be required. Review is stated to take five to seven business days. If approved, refunds are issued to the original payment method within ten to fourteen business days. These are distinct stages, not a single promised bank-arrival date. The supplied terms also omit a central section, limiting a complete review of payment and termination provisions. Our cancellation and refund guide explains the distinction.

Sources: [5] [12]

Identify who evaluates, dispenses and handles delivery problems

The division of responsibility matters when a payment or delivery problem crosses organizational boundaries. Mondae LLC owns and operates the website, while its terms say Mondae does not provide medical services. They describe a contracted physician network and place telehealth services through Bask Telehealth LLC, whose listed mailing address is 555 Madison Ave., Suite 1202, New York, NY 10022. The homepage says state-licensed U.S. clinicians prescribe and licensed U.S. pharmacies dispense. These are provider representations, not independently verified credentials; the supplied material does not name the dispensing pharmacies.

If medication is prescribed, Mondae advertises direct-to-home shipping with tracking and describes it as quick and discreet, without a quantified arrival promise. Damaged or defective medication must be reported by email within 48 hours of delivery, with photos of the medication and original packaging. Confirmed problems generally receive a replacement at no additional cost; a refund is offered only if replacement is impossible. Confirmed incorrect orders likewise receive the correct medication without an additional charge. The documentation does not establish routine shipping fees, cold-chain procedures, carriers or shipment frequency.

Sources: [12] [6] [5]

Confirm availability and a working contact path

Mondae’s FAQ advertises availability in all 50 states, but its terms limit use to people located in the United States and condition access on the state and service involved. That is not confirmation that every advertised treatment is available everywhere. The terms generally describe users as 18 or older, mention parental consent in an age-related exception and warn that some services may require being over 21. Meanwhile, the privacy policy says it does not knowingly permit under-18 access accounts. These provisions do not establish a pediatric program or specific GLP-1 eligibility criteria.

Purchase support is advertised from 8 a.m. to 8 p.m. Eastern, without specified days in that passage. Refund and delivery-problem policies direct patients to email, but the supplied addresses are obscured rather than usable, verifiable contact details. Establish a working support route before relying on a time-sensitive claim. For clinical questions, Mondae advertises secure portal messaging, distinct from ordinary texts and emails that its terms describe as unencrypted. Its privacy policy also warns that sensitive personal data may be sold, with consent where required—an important consideration when completing a health questionnaire.

Sources: [6] [12] [10] [5]

A compounded-drug price is not evidence of equivalent treatment

The regulatory distinction belongs in the cost comparison. FDA explains that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. Nonapproval alone does not establish clinical inequivalence, and a low or high price does not settle product quality. FDA recommends compounded drugs for patients whose medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Approval concerns a specific drug product, not a telehealth platform. Published trials do not establish outcomes for Mondae’s service or its compounded preparations.

Product handling and follow-up can also affect whether an apparently affordable arrangement meets a patient’s needs. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy. That safety advice is separate from a seller’s refund deadline. FDA has also received reports of compounded-medication measurement or administration errors, some involving hospitalization. Patients should obtain clear instructions from the prescriber or pharmacist, not calculate doses from this review. Budgeting should leave room for the actual follow-up arrangement, which Mondae’s supplied documentation does not fully price.

Sources: [1] [2] [3] [4]

Questions & answers

What does Mondae charge for compounded semaglutide?

Its homepage advertises compounded semaglutide from $69 per month, while the product page displays $87 per month next to one-, three- and six-month options. The supplied text does not identify which option carries that figure or explain the difference. Neither amount establishes your first checkout charge, shipment quantity or complete service cost. Obtain the applicable plan price and payment schedule in writing rather than assuming the lowest advertisement applies.

Sources: [6] [11]
Is Mondae’s tirzepatide price an introductory offer?

The documentation does not establish that. The homepage says compounded tirzepatide starts at $114 per month; the product page shows $126 per month alongside three duration choices. No supplied explanation identifies a promotional period or a scheduled increase. Mondae says dose changes do not raise the monthly price and conditions its starting-rate promise on keeping membership active. Ask which starting rate applies and what happens after an interruption.

Sources: [6] [7]
Will I pay if Mondae’s clinician does not prescribe medication?

The supplied policies do not give a consistent answer. The homepage says no charge occurs until a physician approves treatment. The refund policy separately says consultation fees are nonrefundable even when no medication is prescribed. Because no consultation amount or reconciliation is provided, ask specifically whether an unsuccessful evaluation creates any charge, when it is collected and whether the no-charge statement covers clinical fees as well as medication.

Sources: [6] [5]
Can I cancel a Mondae order before it arrives?

Arrival is not the cancellation cutoff. Mondae allows cancellation only before medication has been dispensed or shipped, so a not-yet-delivered order may already be ineligible. A successful cancellation before shipping has a stated refund-issuance window of five to seven business days. That does not guarantee when funds reach your bank or establish that a consultation fee is refundable. Future membership billing requires separate clarification because its cancellation procedure is not established here.

Sources: [5]
Does Mondae accept insurance or Medicare?

No, according to its terms. Mondae and its providers say they do not accept commercial insurance, are not in commercial networks and do not participate in Medicare or Medicaid. Services are obtained on a cash-pay basis outside those programs. This is a statement about Mondae’s payment model, not a determination of your eligibility for a treatment or reimbursement elsewhere. A written itemized quote remains important because the complete included-fee package is unresolved.

Sources: [12] [11]
How does Mondae handle damaged or incorrect medication?

For damaged or defective medication, its policy requires an email report within 48 hours of delivery plus photographs of the medication and original packaging. Confirmed damage generally leads to a no-additional-cost replacement; a refund is offered only if replacement is impossible. Confirmed incorrect orders receive the correct medication without additional cost. Establish a usable contact address beforehand. Separately, FDA advises not using an injectable GLP-1 delivery that is warm or insufficiently refrigerated and contacting the provider or pharmacy.

Sources: [5] [1]

Our assessment

Mondae offers a recognizable cash-pay telehealth pathway, published prices, clinician review, portal messaging and tracked home delivery. Its stated dose-independent monthly rate could help budgeting if the applicable starting price and membership conditions are confirmed. But the documentation does not yet support a dependable all-in budget: homepage and product-page figures differ, plan-payment relationships are unclear, included fees are incompletely specified, and the no-charge-before-approval statement sits uneasily beside nonrefundable consultation fees. The practical next step is a written quote identifying the exact preparation, applicable plan, amount collected now, future billing schedule, included services and cancellation process. Also resolve the consultation-charge conflict and obtain usable clinical, pharmacy and purchase-support contacts. Mondae’s advertised numbers are worth documenting, but they should not be treated as a complete financial commitment—or a promise of treatment results.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

  1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
  2. NIDDK: prescription medications for overweight and obesity ↗
  3. Wilding et al. (2021): STEP 1 semaglutide trial ↗
  4. Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
  5. Mondae — policies/refunds ↗
  6. Mondae — official website ↗
  7. Mondae — treatments/compounded tirzepatide ↗
  8. Mondae — treatments/glutathione ↗
  9. Mondae — treatments/nad ↗
  10. Mondae — policies/privacy policy ↗
  11. Mondae — treatments/compounded semaglutide ↗
  12. Mondae — policies/terms of service ↗
  13. Mondae — treatments/sermorelin ↗

Continue reading